Medtronic markets its products aggressively. Their product, InFuse, has been a big hit in spinal surgeries, and now is also sold for dental surgeries. However, the marketing of InFuse has been riddled with corruption, and now lawsuits for devastating damage are emerging.InFuse is the brand name for BMP-2,recombinant human bone morphogenetic protein-2. It is used to stimulate bone growth as an alternative to bone grafting. It was first approved by the FDA in 1999 for anterior lumbar fusions, but off-label uses were rapidly devised and Medtronic illegally marketed those off-label uses. In the face of clear indications of severe harm from InFuse, the FDA approved its use in dentistry in 2007.